Trials / Completed
CompletedNCT01381341
To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib.
A Phase 1 Pharmacokinetic Study To Compare the Relative Bioavailability of Two Clinical Formulations of Linifanib in Subjects With Solid Tumors
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- Abbott · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A pharmacokinetic study to compare 2 clinical formulations of linifanib.
Detailed description
This study is designed to evaluate the bioavailability of linifanib from 2 formulations. Subjects may enroll in a separate extension study to continue receiving linifanib after completion of this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | linifanib | QD on Day 1 of Periods 1 and 2 |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2011-12-01
- Completion
- 2011-12-01
- First posted
- 2011-06-27
- Last updated
- 2012-03-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01381341. Inclusion in this directory is not an endorsement.